<--- Back to Details
First PageDocument Content
Imiglucerase / Adverse effect
Date: 2016-03-02 15:52:19
Imiglucerase
Adverse effect

PRODUCT MONOGRAPH Pr VPRIV®

Add to Reading List

Source URL: www.shirecanada.com

Download Document from Source Website

File Size: 411,75 KB

Share Document on Facebook

Similar Documents

Imiglucerase / Adverse effect

PRODUCT MONOGRAPH Pr VPRIV®

DocID: 1lQxH - View Document

Clinical pharmacology / Health / Medical prescription / Patient safety / Imiglucerase / Pharmacy / Medical necessity / Ohio Automated Rx Reporting System / Pharmaceutical sciences / Medicine / Pharmacology

UTAH DEPARTMENT OF HEALTH, PRIOR AUTHORIZATION REQUEST FORM CEREZYME (imiglucerase) Patient name:___________________________________Medicaid ID #:________________________________ Prescriber Name:_________________Prescrib

DocID: HI8b - View Document

Clinical research / Biotechnology / Protalix BioTherapeutics / Food and Drug Administration / Genzyme / Taliglucerase alfa / Imiglucerase / Biologic / Pharmaceutical industry / Pharmacology / Pharmaceutical sciences / Biology

NEWS IN FOCUS BIOT ECHNO LO GY Drug-making plant blooms Approval of a ‘biologic’ manufactured in plant cells may pave the way for similar products. BY AMY MAXMEN

DocID: CPXw - View Document

Pharmaceutical sciences / Genzyme / Sanofi / Orphan drugs / Glycogen storage disease type II / Alglucosidase alfa / Prescription Drug User Fee Act / Imiglucerase / Alpha-galactosidase / Medicine / Health / Food and Drug Administration

United States Court of Appeals For the First Circuit No[removed]IN RE: GENZYME CORP. SECURITIES LITIGATION,

DocID: sdi9 - View Document

Clinical research / Biotechnology / Protalix BioTherapeutics / Food and Drug Administration / Genzyme / Taliglucerase alfa / Imiglucerase / Biologic / Pharmaceutical industry / Pharmacology / Pharmaceutical sciences / Biology

NEWS IN FOCUS BIOT ECHNO LO GY Drug-making plant blooms Approval of a ‘biologic’ manufactured in plant cells may pave the way for similar products. BY AMY MAXMEN

DocID: oPuc - View Document